Connect Sign In
Visit booth #915 to explore the latest in diagnostic laboratory testing and discuss your testing needs with ARUP experts.
ARUP Laboratories continues to build a strong portfolio of neurology testing to reflect current scientific advancements. New test options will be highlighted at the upcoming American Academy of Neurology (AAN) Annual Meeting. Held in San Diego, California, from April 5 through 9, the conference provides neurology professionals with educational sessions, insights into the latest research, and opportunities to engage with peers and colleagues.
One presentation that should not be missed is by Kelly Doyle, PhD, DABCC, FADLM, ARUP medical director of Special Chemistry and Endocrinology. He has worked on the validation of ARUP’s soon-to-be-available plasma phosphorylated tau 217 (pTau 217) biomarker test for Alzheimer’s disease (AD). The biomarker pTau 217 has shown strong correlation with amyloid pathology as measured by positron emission tomography (PET) imaging and cerebrospinal fluid (CSF)-based biomarkers in the diagnosis of AD. Doyle will present on the clinical and analytical performance characteristics of the assay in relation to current guidelines on assay performance from the Global CEO Initiative Working Group.
Innovative Insights: Clinical and Analytical Performance of ARUP’s Plasma pTau 217 Quanterix SP-X® Chemiluminescent Assay
Located next to the meeting suites in the exhibit hall
Monday, April 7, 2025
3:30 p.m.
In addition, ARUP neurology specialists, Lisa K. Peterson, PhD, D(ABMLI), ARUP medical director of Immunology, and Tammy Smith, MD, PhD, ARUP clinical consultant of Autoimmune Neurology, will also share their research as co-authors on two posters.
The Urgent Need for Evidence Over Anecdote: Equipoise in the ExTINGUISH Clinical Trial in Anti-NMDAR Encephalitis
Poster Session 7
Monday, April 7, 2025
5–6 p.m.
Shooting in the Dark? A Single-Center Experience of Neural Autoantibody Panel Testing
Poster Session 9
Tuesday, April 8, 2025
11:45 a.m.–12:45p.m.
The latest advancements in diagnostic laboratory testing for autoimmune neurology, epilepsy, developmental delay, intellectual disability, and autism spectrum disorder will be featured at ARUP’s booth (#915). Our experts will be available at the booth to discuss your testing needs.
Refer to the Neurology testing specialties page to learn more about ARUP’s test offerings.
Alice To, alice.to@aruplab.com
